Epidermal growth factor receptor in corneal damage: Update and new insights from recent reports

Cutaneous and Ocular Toxicology

Volumn 30, Issue 1, 2011, Pages 7-14

  Márquez, E Bonafonte ^a   Ortueta, D De ^b   Royo, S Bonafonte ^a   Martínez Carpio, Pedro A ^a,c  

^a Centro de Oftalmología Bonafonte Barcelona   (Spain)

^b Augenlaserzentrum Recklinghausen   (Germany)

^c IMC Investiláser ^*  (Spain)

Author keywords

chemotherapy; cornea; corneal burns; corneal wound healing; diabetic keratopathy; dry eye; epidermal growth factor; Epidermal growth factor receptor; keratopathy; penetrating keratoplasty; refractive surgery

Indexed keywords

CALCIUM; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; PLACEBO; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; RECOMBINANT EPIDERMAL GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; AUTOPHOSPHORYLATION; CALCIUM CELL LEVEL; CAUSTIC BURN; CELL MIGRATION; CELL PROLIFERATION; CORNEA CELL; CORNEA INJURY; CORNEA TRANSPLANTATION; DIABETES MELLITUS; DIABETIC KERATOPATHY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRY EYE; EPIDERMIS CELL; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; KERATOMILEUSIS; KERATOPATHY; KERATOPLASTY; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFRACTIVE SURGERY; SIGNAL TRANSDUCTION; SKIN CELL; WOUND HEALING;

ANIMALS; CELL PROLIFERATION; CORNEA; EPIDERMAL GROWTH FACTOR; EPITHELIUM, CORNEAL; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; REGENERATION; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 79951632108     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2010.498398     Document Type: Article

References (56)

1. Carpenter G, Cohen S. Epidermal growth factor. Minireview. J Biol Chem 1990;265:7709-7712.
2. Schneider MR, Wolf E. The epidermal growth factor receptor ligands at a glance. J Cell Physiol 2009;218:460-466.
3. Sorkin A, Goh LK. Endocytosis and intracellular trafficking of ErbBs. Exp Cell Res 2009;315:683-696.
4. 1 in MDA-MB-231 breast cancer cell line in 11-day cultures. Cellular Signalling 1999;11:753-757. (Pubitemid 29458900)
5. 1 in MDA-MB-231 cell line in 42-hour-long cultures. Cancer Lett 1999;147:25-29.
6. Martínez-Carpio PA, Navarro MA. Growth factors, cell damage, cyclin-dependent kinases and their inhibitors: relevance in molecular pathology of human cancer. Med Clin Barc 2003;120:265-271. (Pubitemid 36336268)
7. Nishida T. The cornea: stasis and dynamics. Nippon Ganka Gakkai Zasshi 2008;112:179-212.
8. Tripathi BJ, Kwait PS, Tripathi RC. Corneal growth factors: a new generation of ophthalmic pharmaceuticals. Cornea 1990;9:2-9. (Pubitemid 20069456)
9. Tripathi BJ, Raja SC, Tripathi RC. Prospects for epidermal growth factor in the management of corneal disorders. Surv Ophthalmol 1990;34:457-462. (Pubitemid 20184864)
10. Hoppenreijs VP, Pels E, Vrensen GF, Treffers WF. Corneal endothelium and growth factors. Surv Ophthalmol 1996;41:155-164. (Pubitemid 26322508)
11. Pancholi S, Trullo A, Khaliq A, Foreman D, Boulton M. The, effects of growth factors and conditioned media on the proliferation of human corneal epithelial cells and keratocytes. Graefes Arch Clin Exp Ophthalmol 1998;236:1-8. (Pubitemid 28080563)
12. Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. Growth factors: importance in wound healing and maintenance of transparency of the cornea. Prog Retin Eye Res 2000;19:113-129.
13. Huang BR, Cai LW, Xiang XZ. The basic and applied study on the epidermal growth factor. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2001;23:176-180.
14. Gönül B, Erdogan D, Ozogul C, Koz M, Babul A, Celebi N. Effect of EGF dosage forms on alkali burned corneal wound healing of mice. Burns 1995;21:7-10.
15. Dartt DA. Interaction of EGF family growth factors and neurotransmitters in regulating lacrimal gland secretion. Exp Eye Res 2004;78:337-345. (Pubitemid 38183310)
16. Boucher I, Yang L, Mayo C, Klepeis V, Trinkaus-Randall V. Injury and nucleotides induce phosphorylation of epidermal growth factor receptor: MMP and HB-EGF dependent pathway. Exp Eye Res 2007;85:130-141. (Pubitemid 47017273)
17. Yin J, Yu FS. ERK1/2 mediate wounding and G-proteincoupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding. Invest Ophthalmol Vis Sci 2009;50:132-139.
18. Xu KP, Li Y, Ljubimov AV, Yu FS. High glucose suppresses epidermal growth factor receptor/phosphatidylinositol 3-kinase/Akt signaling pathway and attenuates corneal epithelial wound healing. Diabetes 2009;58:1077-1085.
19. Akhtar S, Almubrand T, Bron AJ, Yousif MH, Benter IF, Akhtar S. Role of epidermal growth factor receptor (EGFR) in corneal remodelling in diabetes. Acta Ophthalmol 2009;87:881-889.
20. Fabricant R, Salisbury JD, Berkowitz RA, Kaufman HE. Regenerative effects of epidermal growth factor after penetrating keratoplasty in primates. Arch Ophthalmol 1982;100:994-995. (Pubitemid 12119266)
21. Schultz GS, Davis JB, Eiferman RA. Growth factors and corneal epithelium. Cornea 1988;7:96-101.
22. Caporossi A, Manetti C. Epidermal growth factor in topical treatment following epikeratoplasty. Ophthalmologica 1992;205:121-124. (Pubitemid 23004032)
23. Kammann JP, Vollenberg C. Effect of corneal collagen shields and epithelial growth promoting factors on epithelization of the human cornea. Klin Monatsbl Augenheilkd 1994;205:201-209. (Pubitemid 24339420)
24. Usuki Y, Katakami C, Yamamoto M. The effect of epidermal growth factor on keratocytes during healing of corneal penetrating incision. Nippon Ganka Gakkai Zasshi 1995;99:1209-1213.
25. Schüller S, Knorr M, Steuhl KP, Thiel HJ. Lacrimal secretion of human epidermal growth factor in perforating keratoplasty. Geriatr J Ophthalmol 1996;5:268-274.
26. Lohmann CP, Hoffmann E, Reischl U. Epidermal growth factor (EGF) in tears in excimer laser photorefractive keratectomy. Responsible for postoperative refraction and "haze'. Ophthalmologe 1998;95:80-87. (Pubitemid 28164102)
27. Tomas-Barberan S, Schultz GS, Tarnuzzer RW, Fagerholm P. Messenger RNA levels for genes involved in extracellular matrix from human corneal scrapings before and after photorefractive keratectomy. Acta Ophthalmol Scand 1998;76:568-572. (Pubitemid 28482383)
28. Denk PO, Knorr M. Effect of heparin on human corneal fibroblast proliferation in vitro with and without growth factor stimulation. Graefes Arch Clin Exp Ophthalmol 1999;237:342-347. (Pubitemid 29145813)
29. Szaflik J, Fryczkowski AW, Liberek I, Czubak M, Brix M, Broniek G,, et al. Corneal wound healing after penetrating keratoplasty with EGF application. Experimental studies. Klin Oczna 1999;101:409-416.
30. Dai C, Liu X. Effects of epidermal growth factor on wound healing of penetrating keratoplasty in rabbits. Yan Ke Xue Bao 2000;16:228-230.
31. Lohmann CP, Winkler von Mohrenfelds C, Reischl U, Muller A, Guell JL. Screening of myopic LASIK patients with increased epithelial wound healing. Ophthalmologe 2001;98:460-465.
32. Tuli SS, Liu R, Chen C, Blalock TD, Goldstein M, Schultz GS., Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Curr Eye Res 2006;31:709-719. (Pubitemid 44373542)
33. Nakamura Y, Sotozono C, Kinoshita S. The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis. Exp Eye Res 2001;72:511-517. (Pubitemid 32977221)
34. Zhang G, Basti S, Jampol LM. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and review of literature. Cornea 2007;26:858-860. (Pubitemid 47220560)
35. Johnson KS, Levin F, Chu DS. Persistent corneal epithelial defect associated with erlotinib treatment. Cornea 2009;28:706-707.
36. Förster CG, Cursiefen C, Kruse FE. Topical application of EGF for the therapy of persisting corneal erosion under cetuximab treatment. Ophthalmologe 2008;105:269-273.
37. Carrier P, Deschambeault A, Talbot M, Giasson CJ, Auger FA, Guérin SL,, et al. Characterization of wound reepithelization using a new human tissue-engineered corneal wound healing model. Invest Ophthalmol Vis Sci 2008;49:1376-1385.
38. Pastore S, Mascia F, Mariani V, Girolomoni G. The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 2008;128:1365-1374. (Pubitemid 351693180)
39. Wang L, Wormstone IM, Reddan JR, Duncan G. Growth factor receptor signalling in human lens cells: role of the calcium store. Exp Eye Res 2005;80:885-895. (Pubitemid 40798055)
40. Yang H, Mergler S, Sun X, Wang Z, Lu L, Bonanno JA,, et al. TRPC4 knockdown suppresses epidermal growth factor-induced store-operated channel activation and growth in human cornal epithelial cells. J Biol Chem 2005;280:32230-32237. (Pubitemid 41361830)
41. Wang Z, Yang H, Zhang F, Pan Z, Capó-Aponte J, Reinach PS. Dependence of EGF-induced increases in corneal epithelial proliferation and migration on GSK-3 inactivation. Invest Ophthalmol Vis Sci 2009;50:4828-4835.
42. Chandler HL, Kusewitt DF, Colitz CM. Modulation of matrix metalloproteinases by ultraviolet radiation in the canine cornea. Vet Ophthalmol 2008;11:135-144. (Pubitemid 351589457)
43. Xu XP, Yin J, Yu FS. Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor. Invest Ophthalmol Vis Sci 2007;48:636-643. (Pubitemid 351260695)
44. Danasu A. The cutaneous epidermal growth factor network: can it be translated clinically to stimulate hair growth? Dermatol Online J 2009;15:1.
45. Lozano JS, Chay EY, Healey J, Sullenberger R, Klarlund JK. Activation of epidermal growth factor receptor by hydrogels in artificial tears. Exp Eye Res 2008;86:500-505.
46. Yeh S, Fine HA, Smith JA. Corneal verticillata after dual anti-epidermal growth factor receptor and anti-vascular endothelial growth factor receptor 2 therapy (vandetanib) for anaplastic astrocytoma. Cornea 2009;28:699-702.
47. Saif MW, Gnanaraj J. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer. Cutan Ocul Toxicol 2010;29:62-66.
48. Yin J, Yu FS. LL-37 promotes high glucose-attenuated epithelial wound healing via EGFR transactivation in organ cultured corneas [abstract]. Invest Ophthalmol Vis Sci. 2009.
49. Kenchegowda S, Bazan HE. Significance of lipid mediators in corneal injury and repair [abstract]. J Lipid Res. 2009.
50. Huo Y, Qiu WY, Pan Q, Yao IF, Xing K, Lou MF. Reactive oxygen species (ROS) are essential mediators in epidermal growth factor (EGF)-stimulated corneal epithelial cell proliferation, adhesion, migration, and wound healing [abstract]. Exp Eye Res. 2009.
51. Salman IA, Gündogdu C. Epithelial healing in experimental corneal alkali wounds with nondiluted autologous serum eye drops [abstract]. Cutan Ocul Toxicol.2010.
52. Teramura Y, Ichinose J, Takagi H, Nishida K, Yanagida T, Sako Y. Single-molecule binding on the surface of living cells. EMBO J 2006;25:4215-4222.
53. Shao Y, Hu D, Chen J. A study on effect of bFGF, EGF and NGF on growth of cultured human corneal endothelial cells. Yan Ke Xue Bao 2008;24:9-12.
54. Gönül B, Erdogan D, Ozogul C, Koz M, Babul A, Celebi N. Effect of EGF dosage forms on alkali burned corneal wound healing of mice. Burns 1995;21:7-10.
55. Celebi N, Erden N, Gönül B, Koz M. Effects of epidermal growth factor dosage forms on dermal wound strength in mice. J Pharm Pharmacol 1994;46:386-387. (Pubitemid 24140944)
56. Rao K, Farley WJ, Pflugfelder SC. Association between high tear epidermal growth factor levels and corneal subepithelial fibrosis in dry eye conditions. Invest Ophthalmol Vis Sci 2010;51:844-849.